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 Abstract
Objectives: To analyse I/D polymorphism of ACE gene in women with diagnosed endometriosis and to determine 
the correlation of the identified genotypes with the stage of the disease and its clinical picture. 
Material and methods: The analysis of ACE I/D gene polymorphism was performed in a group of 121 women 
with endometriosis and in the control group of 122 women. In the study group the stage of the disease, number of 
pathological foci, occurrence of chronic pain in pelvis minor and infertility were taken into consideration. 
Results: In the study group the following distribution was found of ACE gene genotypes: II – 25.62%, ID – 47.93%, 
DD – 26.45%, whereas in the control group: II – 35.25%, ID – 41.80%, DD – 22.95%. The comparison of the 
frequency of analysed genotypes and alleles between the study and control groups did not demonstrate statistically 
significant differences (p>0.05). Similarly no correlation was found for these parameters when the four stages of the 
disease acc. to rAFS (p>0.05) were compared. In the study group the frequency was compared of the analysed 
ACE gene genotypes and alleles in women with infertility (n=59) and in fertile women (n=62). The comparison of 
these parameters did not demonstrate statistically significant differences between the analysed groups (p>0.05). 
The frequency of genotype II was 17.07%, ID – 46.34% and DD – 36.59% in women with endometriosis complaining 
of pain (n=41). In the group of women with endometriosis without pain the frequency of the investigated genotypes 
(II, ID, DD) was respectively: 26.53%, 59.18%, 14.29%. DD genotype and D allele were more frequent in patients 
with pain complaints (p<0.05).
Conclusion: In analysed population no association was found of ACE I/D polymorphism and the prevalence of 
endometriosis, its stages or the number of disease foci. However, the association of DD genotype and D allele with 
the occurrence of pain within pelvis minor in women with endometriosis was found. 
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Introduction
Endometriosis	 is	 a	 benign	 estrogen-dependent	 disease	
of	 women,	 mainly	 during	 their	 reproductive	 years,	 when	
endometrial	cells	grow	outside	of	the	uterus	which	evokes	chronic	
inflammatory	reaction.	Pelvis	minor	organs	and	peritoneal	surface	
are	the	locations	most	frequently	affected	[1].	Endometriosis	 is	
most	often	divided	into	three	categories:	peritoneal	endometriosis,	
ovarian	endometrial	cysts	and	rectouterine	pouch	endometriosis	
[2].	Occasionally	endometriosis	can	also	develop	in	other	parts	
of	the	body	e.g.	in	lungs,	appendix.	It	has	been	estimated	that	it	
occurs	in	about	10%	of	women	in	their	reproductive	years	but	it	
increases	even	to	35-50%	of	women	complaining	of	pelvic	pain	
or	infertility	[3,	4].	
Aetiology	of	endometriosis	has	not	been	explained	although	
there	exist	several	theories	competing	with	each	other.	Retrograde	
menstruation	 is	 thought	 to	be	one	of	 the	causes	of	 the	disease.	
During	a	woman’s	menstrual	flow	some	of	the	menstrual	effluent	
goes	in	reverse	into	the	peritoneal	cavity	(implantation	theory).	
There	comes	to	ectopic	implantation	of	endometrial	cells	in	the	
peritoneum	and	 to	 establishment	 of	 the	 disease	 foci	 [5].	Other	
frequently	mentioned	and	already	classical	theories	explaining	the	
development	of	endometriosis	are	 the	theory	of	metaplasia	and	
the	theory	of	induction	[1].	Furthermore,	short	menstrual	cycle,	
prolonged	menstrual	bleeding	and	small	number	of	 labours	are	
factors	increasing	the	risk	of	endometriosis	development	[1,	4,	5].	
In	recent	years,	the	share	of	the	angiogenesis	in	the	development	
and	 persistence	 of	 endometriosis	 foci	 in	 peritoneal	 cavity	 has	
been	indicated	[4-6].
Angiopoetins,	 increasing	 the	 exposure	 of	 endothelial	 cells	
to	 the	 activity	of	 angiogenic	 factors,	matrix	metalloproteinases	
(MMP)	 degrading	 the	 components	 of	 extracellular	 matrix	 and	
facilitating	penetration	of	newly	formed	blood	vessels,	vascular-
endothelial	 growth	 factor	 (VEGF)	 and	 interleukins	 (IL-8	 and	
IL-6)	are	the	factors	playing	an	important	role	in	the	process	of	
neovascularisation	in	endometriosis	[4-7].	
Genetic	 factors	 also	 play	 a	 role	 in	 the	 development	 of	
endometriosis	[3,	8-10].	In	the	case	of	severe	endometriosis	the	
occurrence	of	hereditary	predispositions	of	multigene	inheritance	
is	 observed	 [11].	 The	 contribution	 of	 a	 genetic	 factor	 in	 the	
development	of	endometriosis	was	also	confirmed	by	studies	on	
monozygotic	 twins	 [9].	 Up	 till	 now,	 multiple	 candidate	 genes	
have	 been	 analysed	 as	 their	 involvement	 in	 the	 pathogenesis	
of	 endometriosis	 seems	 to	 be	 of	 major	 importance,	 among	
others:	genes	encoding	cytokines	and	pro-inflammatory	factors,	
adhesive	 proteins	 and	 extracellular	 matrix	 enzymes,	 growth	
factors,	cell	cycle	and	apoptosis	regulatory	proteins,	receptors	for	
hormones	[reviewed	9,	10].	Renin-angiotensin	system	(RAS)	was	
suggested	to	be	another	factor	contributing	to	the	development	of	
endometriosis.	It	acts	as	hormonal	system	[12].
The	RAS	gene	system	comprises	the	renin,	angiotensinogen	
(AGT),	angiotensin	I	converting	enzyme	(ACE)	and	angiotensin	II	
receptor	types	1	and	2	(AT1,	AT2)	genes.	[13].	Renin	is	synthesized	
in	 kidneys	 and	 released	 from	 granular	 juxtaglomerular	 cells.	
This	enzyme	demonstrates	aspargine	protease	activity	and	takes	
part	 in	 angiotensinogen	 (synthesized	 in	 liver)	 to	 	 angiotensin	
I	 conversion.	 Then,	 angiotensin	 I	 is	 converted	 to	 angiotensin	
II	–	a	key	compound	of	RAS	system	which	transmits	the	signal	
into	the	cells	through	membrane	receptors	of	type	1	and	2	[13].	
Besides	angiotensin	systemic	activity	its	local	(tissue)	potential	
is	emphasized.	Deletion	of	287-base	pair	fragment	in	intron	16	of	
ACE	gene	results	in	increased	level	of	angiotensin	I	convertase	
in	plasma	[14].
 Streszczenie
Cel pracy: Analiza polimorfizmu I/D genu ACE u kobiet ze zdiagnozowaną endometriozą oraz określenie korelacji 
zidentyfikowanych genotypów ze stopniem zaawansowania choroby i jej obrazem klinicznym.
Materiał i metody: Przeprowadzono analizę polimorfizmu I/D genu ACE w grupie 121 kobiet z endometriozą 
i 122 kobiet z grupy kontrolnej. W grupie badanej wzięto pod uwagę stopień zaawansowania i liczbę ognisk choroby, 
występowanie przewlekłego bólu miednicy mniejszej i bezpłodności.
Wyniki: W grupie badanej stwierdzono następujący rozkład genotypów genu ACE: II – 25,62%, ID – 47,93%, DD 
– 26,45%, a w grupie kontrolnej: II – 35,25%, ID – 41,80%, DD – 22,95%. Porównanie częstości występowania 
badanych genotypów i alleli pomiędzy grupą badaną i kontrolną nie wykazało różnic istotnych statystycznie 
(p>0,05). Podobnie brak korelacji dla tych parametrów zaobserwowano w przepadku porównania czterech stopni 
zaawansowania choroby wg. rAFS (p>0,05). 
W grupie badanej porównano częstość występowania analizowanych genotypów i alleli genu ACE u kobiet 
z niepłodnością (n=59) i płodnych kobiet (n=62). Analiza tych parametrów nie wykazała różnic statystycznie 
istotnych pomiędzy badanymi grupami (p>0,05). U kobiet z endometriozą, które uskarżały się na ból (n=41) genotyp 
II występował z częstością 17,07%, ID – 46,34%, DD – 36,59%. W grupie kobiet z endometriozą, u których ból 
nie występował, badane genotypy (II, ID, DD) występowały odpowiednio z częstością: 26,53%, 59,18%, 14,29%. 
Genotyp DD i allel D występował częściej u kobiet z dolegliwościami bólowymi (p<0,05). 
Wnioski: W badanej populacji kobiet nie wykazano istnienia związku między polimorfizmem genotypu I/D genu 
ACE, a występowaniem endometriozy, stopniem jej zaawansowania oraz liczbą ognisk choroby. Natomiast 
wykazano związek genotypu DD i allelu D z występowaniem u kobiet z endometriozą objawów bólowych w obrębie 
miednicy mniejszej.
 Słowa kluczowe: endometrioza / enzym konwertujący angiotensynę / 
       / genetyczny polimorfizm / ból miednicy mniejszej / 
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Objectives
The	aim	of	the	study	was	the	analysis	of	insertion/deletion	
polymorphism	 in	 the	 angiotensin	 I	 converting	 enzyme	 gene	
(ACE)	in	women	with	diagnosed	endometriosis	and	to	determine	
the	correlation	of	the	identified	genotypes	with	the	stage	of	the	
disease	and	its	clinical	picture.
Material and methods
Subjects
A	 cohort	 of	 121	 women	 diagnosed	 upon	 laparoscopic 
examination	 with	 different	 stages	 (I	 –	 minimal,	 II	 –	 mild,	 III	
–	 moderate,	 IV	 -	 severe)	 of endometriosis	 using	 the	 revised	
American	 Fertility	 Society (rAFS)	 classification	 system	 [15]	
were	 recruited	 at	 the	 Department	 of	 Surgical	 and	 Endoscopic	
Gyneacology,	Polish	Mother’s	Memorial	Hospital,	Lodz,	Poland.	
Twenty-nine	 patients were	 classified	 as	 stage	 I	 of	 the	 disease	
(mean	 age	 32.1±4.7,	 range	 23-42),	 22	 as	 stage	 II	 (mean	 age	
33.8±5.8,	range	25-51),	35	as	stage	III	(mean	age	33.2±6.8,	range	
21-49)	and	35	patients	were stage	IV	(mean	age	31.2±5.6,	range	
20-56).
A	 population	 of	 122	 women	 without	 endometriosis from	
the	Department	of	Surgical		and	Endoscopic	Gyneacology were 
studied	as	a	control	group	(mean	age	40.8±10.4,	range	22-67).
The	protocol	had	been	previously	approved	by	the	Bioethical	
Committee	of	the	Medical	University	of	Lodz	(RNN/47/09/KB).
Molecular analysis
Genomic	 DNA	 was	 isolated	 from	 the	 peripheral	 blood	
with	 the	 Blood	Mini	 kit	 (DNA-Gdańsk,	 Poland)	 according	 to	
the	manufacturers	 procedure.	Analysis	 of	ACE	 genotypes	 was	
performed	using	polymerase	chain	reaction	(PCR).
The	 primer	 sequences	 were	 as	 follows:	 sense	 primer	 -	
5’CTGGAGACCACTCCCATCCTTTCT3’	and	antisense	primer:	
5’GATGTGGCCATCACATTCGTCAGAT3’,	 as	 described	 by	
Hsieh	and	coworkers	[16].	
PCR	 reaction	 was	 performed	 in	 a	 final	 volume	 of	 50μl	
containing	150ng/sample	of	primers,	0.1	mM/sample	of	dNTPs,	
DNA	 buffer	 1X/sample,	 1.5	 U/sample	 of	Taq	 polymerase	 and	
50ng	 of	 genomic	 DNA.	 The	 DNA	 was	 amplified	 for	 initial	
denaturation	at	94°C	for	5	min.	followed	by	35	cycles	of	94°C	
for	30	sec,	62°C	for	30	sec	and	72°C	for	45	sec	following	a	final	
extension	of	72°C	for	10	min.	(Genius,	Techne).	
The	amplification	products	were	analyzed	by	electrophoresis	
of	5	μl	samples	on	2%	agarose	gels	and	visualizing	with	ethidium	
bromide	staining.	The	products	were	of	the	size	about	190	bp	and	
490	bp	for	I and D	allele	respectively.	(Figure	1).	
Statistical analysis
Statistical	analysis	was	performed	using	the	Statistica	8.0	pl.	
Allele	and	genotype frequencies	were	compared	between	groups	
using	 the	c2	 test	 (or	Fisher’s	 exact	 test	when	necessary).	Non-
parametric	 variables	were	 analyzed	with	 the	U-Mann-Whitney	
test.	P	<0.05	was	considered	statistically	significant.
Results
In	 the	 study	group	 (n=121)	 the	 following	distribution	was	
found	of	ACE	gene	genotypes:	II	–	25.62%	ID	–	47.93%,	DD –	
26.45%,	whereas	in	the	control	group	(n=122):	II –	35.25%, ID 
–	41.80%,	DD –	22.95%.	(Table	I).	
I and D	allele	frequencies	were:	I	–	49.59%,	56.15%;	D	–	
50.41%,	49.85%	respectively	 for	 the	study	and	control	groups.	
(Table	II).	
The	comparison	of	the	frequency	of	II, ID and DD	genotypes	
and I and D alleles	between	the	study	and	control	groups	did	not	
demonstrate	 statistically	 significant	 differences	 (respectively:	
p=0.265;	 p=0.147).	 No	 correlation	 was	 found	 as	 regards	 the	
frequency	 of	 the	 investigated	 genotypes	 (Table	 I)	 and	 alleles	
(Table	II)	when	the	four	stages	of	the	disease	acc.	to	rAFS	were	
compared	(respectively:	p=0.266;	p=0.624).
 
Figure 1. Gel electrophoresis of the ACE I/D polymorphism. 1: DNA size marker (Low Range); II: 2, 3, 6, 8-10, 13; ID: 4, 12; DD: 5, 7, 11, 14.
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Among	 patients	 with	 endometriosis	 (n=121)	 in	 55	 of	
them	a	single	disease	focus	was	observed,	 in	41-two	and	in	19	
endometrial	lesions	comprised	three	localizations,	in	4	patients	–	
four,	in	2	–	five	localizations.	Table	III	demonstrates	the	frequency	
of	individual	genotypes	of	I/D	polymorphism	in	ACE gene.	The	
comparison	 of	 the	 investigated	 genotypes	 and	 alleles	 between	
these	groups	with	the	use	of	nonparametric	Mann-Whitney	test	
did	 not	 show	 statistically	 significant	 differences	 (respectively:	
p=0.594;	p=0.947).
The	 frequency	 of	 the	 analysed	 ACE	 gene	 genotypes	 and	
alleles	was	compared	in	the	study	group	in	women	suffering	from	
infertility	 (n=59)	 and	 in	 fertile	 women	 (n=62).	 The	 following	
distribution	of	genotypes	was	observed	in	individual	investigated	
groups:	patients	with	infertility:	II	–	22.03%,	ID	–	52.54%,	DD 
–	25.42%;	patients	without	 fertility	disorders:	 II –	29.03,	 ID	 –	
43.55%,	DD	 –	27.42%.	The	 frequency	of	 I and D	 alleles	was:	
I	–	48.31%,	50.81%;	D	–	51.69%,	49.19%	respectively	for	 the	
patients	with	infertility	and	in	those	with	normal	fertility.	(Table	
IV).	The	comparison	of	the	frequency	of	genotypes	and	alleles	of	
ACE	gene	did	not	demonstrate	statistically	significant	differences	
between	both	analysed	groups	(respectively:	p=0.567;	p=0.697).	
Information	was	obtained	from	90	patients	with	diagnosed	
endometriosis	concerning	the	occurrence	of	chronic	pelvic	pain.	
In	patients	who	complained	of	pain	 (n=41)	 the	 frequency	of II 
genotype	 was	 17.07%,	 of	 ID	 genotype	 –	 46.34%	 and	 of	 DD 
genotype	 –	 36.59%.	 The	 frequency	 of	 these	 genotypes	 in	 the	
group	of	patients	with	no	pain	was	respectively:	26.53%,	59.18%,	
14.29%.	(Table	V).	
DD genotype	was	more	frequent	in	patients	with	pelvic	pain	
and	the	difference	was	statistically	significant	(χ2=6.13,	p=0.046).	
Similarly,	the	frequency	of	D	allele	in	this	group	was	significantly	
higher	compared	 to	 the	group	of	patients	with	no	pain	(χ2=4.5,	
p=0.034).		
Discussion 
Endometriosis	 affects	 even	 10%	 of	 all	 reproductive-aged	
women.	 Its	 aetiology	still	 remains	unrecognized.	Endometrium	
is	 one	of	 few	mature	 tissues	which	 is	 distinguished	by	 regular	
periods	of	rapid	growth	and	abruption.	Thus,	angiogenesis	is	an	
important	element	of	this	tissue	functioning.	That	is	why	recently	
it	 has	 been	 suggested	 that	 the	mechanism	 of	 the	 development	
and	 persistence	 of	 this	 disease	 foci	 may	 be	 engaged	 in	 the	
angiogenesis	 [4-7].	 The	 fact	 that	 endometriotic	 implants	 are	
often	surrounded	by	a	network	of	blood	vessels	can	be	a	proof.	
Neovascularization	around	and	inside	endometriotic	lesions	was	
also	confirmed	by	microscopic	analysis	[6].	Inan	et	al.	observed	
increased	expression	of	von	Willebrand	factor	and	CD34	(antigens	
specific	for	vascular	endothelium)	in	endometrial	cysts	in	relation	
to	 the	 tissue	of	normal	ovary	 [17].	 In	 the	authors’	opinion	 this	
proves	the	significant	role	of	neoangiogenesis	in	the	development	
of	 endometriosis.	 Ria	 et	 al.,	 who	 compared	 the	 structure	 of	
blood	vessels	 in	normal	endometrium	and	 in	endometrial	cysts	
came	to	the	same	conclusion	[18].	Immaturity	of	newly	formed	
vessels	 and	 high	 proliferative	 activity	 of	 endothelial	 cells	 in	
active	 inflammatory	 lesions	 were	 also	 observed	 in	 peritoneal	
endometriosis	[5,	19,	20].	
Owing	 to	 reports	 proving	 coexistence	 of	 endometriosis	
and	 neovascularization,	 there	 was	 undertaken	 the	 analysis	
of	 polymorphism	 of	 genes	 engaged	 in	 the	 development	 and	
functioning	of	blood	vessels	 including	also	 the	genes	of	 renin-
angiotensin	system	[10].
RAS	 system	 regulates,	 among	 others,	 blood	 pressure	 by	
influencing	vessel	tension,	renal	haemodynamics	and	water	and	
electrolyte	 balance	 [21].	 The	 studies	 revealed	 that	 angiotensin	
I	 convertase	 is	 present	 on	 the	 surface	 of	 vessel	 epithelial	 cells	
within	 the	whole	 circulatory	 system.	Also	 renin	 released	 from	
kidneys	 can	 be	 captured	 by	 epithelial	 cells.	This	 enables	 local	
production	 of	 angiotensin	 II	 which	 demonstrates	 autocrine/
paracrine	 activity	 [13].	 Furthermore,	 angiotensin	 II	 produced	
in	 tissues	 stimulates	 smooth	 muscle	 vessel	 proliferation.	 The	
contribution	of	RAS	is	also	suggested	as	one	of	the	factors	in	the	
initiation	of	the	menstrual	cycle	[22].	
Table I. Genotype frequencies for ACE I/D gene polymorphism in individuals with and without endometriosis. 
Table II. Alleles frequencies for ACE I/D gene polymorphism in individuals with  
and without endometriosis. 
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To	date,	in	the	available	medical	literature	one	study	can	be	
found	concerning	 the	 analysis	 of	 insertion/deletion	 angiotensin	
I-converting	 enzyme	 gene	 polymorphism	 in	 women	 with	
endometriosis.	 The	 authors	 determined	 ACE gene	 genotype	
in	125	women	with	endometriosis	and	 in	128	 from	the	control	
group.	According	to	the	authors	genotypes	with	insertion	allele	
of	ACE gene	(II, ID)	seem	to	predispose	to	the	development	of	
endometriosis	in	Taiwan	population	[16].
In	 this	 study	 121	 women	 with	 endometriosis	 and	 120	
from	 the	 control	 group	 were	 analysed.	 The	 obtained	 results	
did	 not	 demonstrate	 any	 association	 between	 	ACE  I/D gene 
polymorphism	 and	 the	 prevalence	 of	 endometriosis	 in	 women	
nor	 the	 stage	 of	 the	 disease.	 On	 the	 other	 hand,	 Hsieh	 et	 al.,	
estimated	polymorphism	only	in	women	with	advanced	stage	of	
the	disease,	whereas	 in	 this	 study	 the	 study	group	 included	all	
four	stages	of	the	disease	acc.	to	rAFS	[15,	16].	
Owing	 to	 very	 differentiated	 as	 regards	 localization	 and	
number	 of	 endometrial	 foci	 in	 the	 investigated	 women,	 the	
authors	 divided	 the	 study	 group	 into	 subgroups	 dependently	
on	the	number	of	endometrial	foci.	In	nearly	half	(n=55)	of	the	
investigated	women	endometriosis	was	related	to	one	organ	(most	
frequently	it	was	peritoneum	or	ovary),	in	44	women	the	disease	
occurred	 in	 two	 localizations	 and	 in	 25	 patients	 endometriosis	
affected	three	or	more	sites.	(Table	III).	
Statistical	 analysis	 did	 not	 demonstrate	 any	 association	
between	 the	 number	 of	 the	 foci	 and	 	 ACE I/D gene 
polymorphism.	
Infertility	 is	 one	 of	 the	 main	 symptoms	 accompanying	
endometriosis.	It	has	been	estimated	that	it	affects	even	50%	of	
women	with	 this	disease	 [3,	4].	Despite	 the	visible	association	
between	 endometriosis	 and	 infertility	 the	 mechanism	 of	 this	
dependence	has	not	been	recognized	[23].	Ovulatory	disorders,	
disturbed	 transport	of	gametes	 through	uterine	 tubes,	hormonal	
disorders	 (including	 LH),	 toxic	 effect	 of	 factors	 associated	
with	 inflammatory	 reaction	 on	 fetus	 and	 also	 on	 sperm	 and	
embryo	 implantation	 in	endometrium	are	among	 the	 suggested	
mechanisms	 leading	 to	 fertility	 disturbances	 in	 women	 with	
endometriosis	[23,	24].
To	date,	the	association	has	been	successfully	demonstrated	
of	several	polymorphisms	found	in	human	genome	with	infertility	
of	 women	 suffering	 from	 endometriosis.	 The	 studies	 carried	
out	by	Lamp	et	al.,	 revealed	increased	susceptibility	 to	fertility	
disorders	 in	 patients	with	 endometriosis	when	 two	 types	were	
found	of	polymorphisms	of	 encoding	gene	17β-hydroxysteroid	
dehydrogenase:	HSD17B1	A/G	SNP	A	allele	and	ESR1	 longer	
(TA)n	repeats	[25].	Also	Marfa	et	al.	suggest	that	LHbeta	G1502A	
polymorphism	may	be	involved	in	the	predisposition	to	minimal/
mild	endometriosis-associated	infertility,	although	it	is	not	clear	
if	 endometriosis	 is	 not	 only	 a	 coincidental	 finding	 along	 with	
infertility	[26].
Table III. Genotype and allele frequencies for ACE I/D gene polymorphism in individuals with different number of endometriosis foci. 
Table IV. Genotype and allele frequencies for ACE I/D gene polymorphism in individuals with endometriosis with and without infertility. 
Table V. Genotype and allele frequencies for ACE I/D gene polymorphism in individuals with endometriosis with and without pain. 
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In	our	studies	infertility	was	found	in	59	patients.	No	fertility	
disorders	 were	 observed	 in	 the	 remaining	 62	 patients	 with	
endometriosis.	The	frequency	of	genotypes:	II, ID and DD and 
alleles	 I and D	 of	 I/D ACE	 polymorphism	was	 similar	 in	both	
groups.	 (Table	 IV).	 Insignificant	 differences	which	were	 noted	
were	not	statistically	significant.	
The	major	 symptoms	 of	 endometriosis	 and	 reasons	 for	 its	
treatment,	 besides	 infertility,	 include	 pain	 complaints	 such	 as:	
strong	pain	with	menstrual	and	perimenstrual	periods,	dyspareunia	
and	chronic	pelvic	pain	[3].	The	precise	mechanism	responsible	
for	pain	 in	 the	course	of	endometriosis	has	not	been	known.	 It	
seems	that	this	pain	results	from	both	direct	and	indirect	effect	of	
endometrial	alterations.	The	direct	effect	includes	implantation	of	
endometrial	foci	into	normal	tissues	and	their	periodical	bleeding	
and	stimulation	of	fibrosis.	Indirect	effect	 includes	synthesis	of	
cytokines	 and	other	 proinflammatory	 factors	which	 can	 irritate	
neighbouring	nerve	roots	and	silent	nociceptors	[27].
In	 this	 study	 information	 about	 pelvic	 pain	 was	 obtained	
from	90	patients	with	endometriosis.	In	41	(45.56%)	of	them	the	
pain	occurred,	whereas	the	remaining	49	(54.44%)	of	women	did	
not	complain	of	pain.	The	statistical	analysis	 showed	 that	both	
DD	genotype	and	D	allele	of		ACE  I/D	gene	polymorphism	were	
more	frequent	in	women	with	pain	symptoms	(p<0.05).	
As	it	has	been	already	mentioned,	endometriosis	is	estrogen-
dependent	 and	 thus	 its	 development	 is	 strictly	 dependent	 on	
estrogen	 metabolism.	 The	 level	 of	 oestriol	 (E2)	 in	 menstrual	
blood	 of	 women	 with	 endometriosis	 is	 higher	 compared	 to	
healthy	women	which	suggests	that	this	hormone	is	synthesized	
in	 them	 locally	 in	 endothelium	 [28].	 In	 ectopic	 endometrium	
there	 is	 observed	 a	 disturbed	 level	 of	 expression	 of	 enzymes	
engaged	in	estrogen	metabolism	in	relation	to	normally	localized	
tissue,	 among	 others	 increased	 expression	 of	 aromatase,	
17β-hydroxysteroid	 dehydrogenase	 (17β-HSD)	 type	 1,	 7,	 12,	
or	 decreased	 expression	 of	 	 17β-HSD	 type	 2,	 which	 leads	 to	
excessive	synthesis	of	oestriol	[29].	
The	 studies	 performed	 by	 Chakrabarty	 et	 al.,	 on	 animal	
model	with	the	use	of	rat	nerve	cells	demonstrated	that	oestriol	
on	 signal	 pathway	 in	which	 type	 2	 angiotensin	 receptor	 (AT2)	
is	 engaged,	 stimulates	 growth	 of	 nociceptors.	 Furthermore,	E2	
promotes	neuritogenesis	only	in	the	presence	of	active	ACE	[30].	
It	 has	 been	 known	 that	 DD	 genotype	 of	 ACE	 gene	 increases	
this	enzyme	activity.	The	results	of	studies	of	these	authors	can	
be	 the	 base	 for	 discussion	 why	 increased	 level	 of	 angiotensin	
I	 convertase	 in	 blood	 of	women	 is	more	 frequently	 associated	
with	pain	complaints	than	in	the	patients	with	insertion	allele.	
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